Ascentage Pharma Group International (HKG:6855)
32.48
-1.70 (-4.97%)
Sep 10, 2026, 11:59 AM HKT
HKG:6855 Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, HKG:6855 stock has a consensus rating of "Strong Buy" and an average price target of $71.93. The average 1-year stock price forecast is 121.46% higher than the current stock price, while the lowest is $44.09 (+35.75%) and the highest is $108.46 (+233.93%).
Price Target: $71.93 (+121.46%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:6855 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 6 | 6 | 7 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 7 | 7 | 8 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CICC No rating | CICC | Buy Maintains $45.00 | Buy | Maintains | $45.00 | +38.55% | Aug 27, 2026 |
Unknown Analyst Guoyuan Securities (HK) No rating | Guoyuan Securities (HK) | Buy Maintains $43.73 | Buy | Maintains | $43.73 | +34.64% | Jun 18, 2026 |
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $59.09 | Buy | Maintains | $59.09 | +81.93% | Jun 2, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Buy Maintains $89.00 | Buy | Maintains | $89.00 | +174.01% | Apr 20, 2026 |
Financial Forecast
Revenue This Year
696.83M
from 574.12M
Increased by 21.37%
Revenue Next Year
1.48B
from 696.83M
Increased by 112.93%
EPS This Year
-3.93
from -3.49
EPS Next Year
-0.33
from -3.93
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.